A5037398621- Respiratory viral infections research
- Vaccine Coverage and Hesitancy
- Pneumonia and Respiratory Infections
- Global Maternal and Child Health
- SARS-CoV-2 and COVID-19 Research
- Influenza Virus Research Studies
- COVID-19 Clinical Research Studies
- Hemodynamic Monitoring and Therapy
- COVID-19 epidemiological studies
- Circadian rhythm and melatonin
- COVID-19 Impact on Reproduction
- Bacterial Infections and Vaccines
- Heart Rate Variability and Autonomic Control
- Child Nutrition and Water Access
- Gender, Security, and Conflict
- Non-Invasive Vital Sign Monitoring
- COVID-19 and Mental Health
- Neuroendocrine regulation and behavior
- Viral gastroenteritis research and epidemiology
- Stress Responses and Cortisol
- Pneumocystis jirovecii pneumonia detection and treatment
- SARS-CoV-2 detection and testing
Program for Appropriate Technology in Health
2010-2025
Seattle University
2024
University of Maryland, Baltimore
2023
University of Illinois Chicago
2022
Mayo Clinic in Arizona
2016
Respiratory syncytial virus (RSV) is the predominant cause of acute lower respiratory infection (ALRI) in young children worldwide, yet no licensed RSV vaccine exists to help prevent millions illnesses and hospitalizations tens thousands lives taken each year. Monoclonal antibody (mAb) prophylaxis for prevention a small subset very high-risk infants children, but only currently product impractical, requiring multiple doses expensive low-income settings where disease burden greatest. A robust...
Pneumococcal conjugate vaccines (PCVs) have proven to be the best way prevent severe childhood pneumococcal disease but until recently been difficult for many countries afford sustainably. In 2008, Serum Institute of India, Pvt. Ltd. and PATH entered into a collaboration, funded in part by Bill & Melinda Gates Foundation, respond this problem developing PCV designed affordable, accessible, protective against serotypes causing most morbidity mortality low- middle-income countries. The...
New vaccines for pregnant women have recently been introduced in some high-income countries to protect infants early life. Implementing maternal immunisation (MI) successfully low- and middle-income will require planning adaptations health programs. To inform cost of MI delivery studies, we gathered perspectives from key stakeholders five (Bangladesh, Ghana, Kenya, Mozambique, Nepal) regarding system requirements, opportunities, challenges introducing new into routine
Streptococcus pneumoniae kills nearly 1 million children before their fifth birthdays each year, mostly in the developing world. Current pneumococcal vaccines provide effective, serotype-specific protection, yet no licensed vaccine today offers broad coverage against all of S. pneumoniae's more than 90 serotypes. Although low-income countries are beginning to gain access these lifesaving via assistance from global health partnerships, such otherwise unaffordable for poorer nations due...
New respiratory syncytial virus (RSV) maternal vaccines have begun roll out in some countries, with efforts progress to broaden access worldwide and shorten the timeline for low- middle-income countries (LMICs). Prior new immunization (MI) introductions, will need evaluate their capacity readiness successful introduction. The World Health Organization's Maternal Immunization Antenatal Care Situation Analysis (MIACSA) project (2016–2019) developed a checklist self-evaluate introduce vaccines....
In an increasingly crowded vaccine landscape, global and country decision-makers will require evidence-based disease-specific information when prioritizing new public health interventions. The Advancing Maternal Immunization collaboration (AMI) was designed to develop a cross-program strategy advance respiratory syncytial virus (RSV) maternal immunization (MI) availability accessibility in low- middle-income countries by completing comprehensive RSV MI gap analysis developing actionable...
Slow, deep breathing (SDB) is thought to lead reductions in blood pressure by decreasing vascular‐sympathetic coupling. Venous Occlusion Plethysmography (VOP) used assess forearm flow (FBF) (ml/min/100 dl tissue). We this technique determine the vasodilatory effect of device‐guided (DG) vs self‐paced (SP) slow, breathing. hypothesized that SP would a larger vasodilation response than DG due more profound reduction coupling, and be correlated with psychological evaluations. Young, healthy...